Reversal effect of Phyllanthus emblica (Euphorbiaceae) rasayana on memory deficits in mice

International Journal of Applied Pharmaceutics

Volumn 3, Issue 2, 2011, Pages 10-15

  Ashwlayan, Vrish Dhwaj ^a   Singh, Ranjit ^a  

^a SHOBHIT UNIVERSITY   (India)

Author keywords

Amla; Amnesia; Dementia; Piracetam; Scopolamine; Sodium nitrite

Indexed keywords

EMBLICA OFFICINALIS EXTRACT; METHANOL; PIRACETAM;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; ELEVATED PLUS MAZE; EMBLICA OFFICINALIS; FRUIT; LATENT PERIOD; LEARNING; LONG TERM MEMORY; LOW DRUG DOSE; MALE; MAZE TEST; MEMORY CONSOLIDATION; MENTAL PERFORMANCE; MORRIS WATER MAZE; MOTOR COORDINATION; MOUSE; NONHUMAN; ROTAROD TEST; SHORT TERM MEMORY;

EID: 79959839305     PISSN: None     EISSN: 09757058     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Hyslop ST, Geore PH. Molecular genetics of Alzheimer's disease. Biol Psychiat 2000; 47:183.
2. Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet 2006.
3. Selkoe DJ. Alzheimer's disease: genes, proteins and therapy. Physiol Rev 2001; 81:741-66.
4. Ritchie K, Kildea D. Is senile dementia age-related or ageingrelated? Evidence from meta-analysis of dementia prevalence in the oldest old. Lancet 1995; 346: 931-934.
5. Aevarsson O, Skoog I. A population based study on the incidence of dementia disorders between 85 and 88 years of age. J Am Geriat Soc 1996; 44:1455-1460.
6. Muller WE. Nootropics, the therapy of dementia between aspiration and reality. Drugline 1989, 2: 295-300.
7. Brewer GJ. Age-related toxicity to lactate, glutamate and β- amyloid in cultured adult neurons. Neurobiol Aging 1998; 19:561-568.
8. Sohal RS et al. Age-related changes in antioxidant enzymes and pro-oxidant generation in tissues of the rat with special reference to parameters in two insect species. Free Radic Biol Med 1990; 10:495-500.
9. Nagy IZ. On the true role of oxygen free radicals in the living state, ageing and degenerative disorders. Ann NY Acad Sci 2001; 928: 187-191.
10. Smith JV, Luo Y. Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract Egb 761. J Alzheimer's dis 2003; 5: 287-292.
11. Cumin R. Effects of the novel compound aniracetam (Ro-13- 5057) upon impaired learning and memory in rodents. Psychopharmacol 1982; 78:104-111.
12. Burns A and O'Brien J. Clinical practice with anti-dementia drugs: a consensus statement from British association for psychopharmacology 2006; 20:732.
13. Scartezzini P, Speroni E. Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol 2000; 71: 23-43.
14. Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M. Saliva officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo controlled trial. J Clin Pharm Ther 2003: 28:53-59.
15. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzbeg AF. A placebo controlled, double blind, randomized trial of an extract of Ginkago biloba for dementia. North American EGb study group. Jama 1997; 278:1327-32.
16. Ng TP, Chiam PC, Lee T, Chua HC, Lim L, Kua EH. Curry consumption and cognitive function in the elderly. Am J Epidemol 2006; 164:898-906.
17. Ghosal et al. Active constituents of Emblica officinalis. The chemistry and antioxidant activity of two new hydrolysable tannins, emblicanin A and B. Indian J Chem 1996; 35 (Suppl II): 941-948.
18. Bhattacharya A et al. Antioxidant activity of active tannoid principles of Emblica officinalis (amla). Indian J Exp Biol 1999;37:676-680.
19. Gulcin I et al. Screening of antioxidant and antimicrobial activities of anise (Pimpinella anisum L.) seed extracts. Food Chem 2003, 83:371-382.
20. Minussi RC et al. Phenolic compounds and total antioxidant potential of commercial wines. Food Chem 2003, 82:409-416.
21. Luo et al. Identification of bioactive compounds in Phyllenthus emblica L. fruit and their free radical scavenging activities. Food Chem 2009; 114: 499-504.
22. Jeena et al. Antitumour activity of Emblica officinalis. J Ethnopharmacol 2001; 75: 65-69.
23. Perianayagam JB et al. Evaluation of anti-pyretic and analgesic activity of Emblica officinalis Gaertn. J Ethnopharmacol 2004;95: 83-85.
24. Li et al. Identification of phenolics in the fruit of emblica (Phyllanthus emblica L.) and their antioxidant activities. Food Chemistry 2008; 109:909-915
25. Nosal'ova G et al. Antitussive activity of the fruit extract of Emblica officinalis Gaertn. (Euphorbiaceae) Phytomedicine:2003; 10:583-589.
26. Rehail et al. Gastroprotective effect of Embelica Officinalis on in vivo test models in rats. Phytomedicine: Int J Phytoth Phytopharmacol 9 (Suppl 6), 2002, pp 515-522.
27. Wang et al. Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis. Antiviral Res 2009; 84:150-158.
28. Zhang et al. Antiproliferative Activity of the Main Constituents from Phyllanthus emblica. Biol Pharm Bull 2004; 27 (2): 251-255.
29. Mathur et al. Hypolipidaemic effect of fruit juice of Emblica officinalis in cholesterol fed rabbits. J Ethnopharmacol 1996; 50: 61-68.
30. Gupta VK. The Wealth of India Raw Materials. Vol III: D1, NISCAIR Press, New Delhi, 2002.
31. Dhir et al. Protection afforded by aqueous extracts of Phyllanthus against cytotoxicity induced by lead and aluminum salts. Phytoter Res 1990; 4: 172-176.
32. Roy AK. Modification of metal induced micronuclei formation in mouse bone marrow erythrocytes by Phyllanthus fruit extract and ascorbic acid. Toxicol Letters 1992; 62:9-11.
33. Ong ES. Extraction methods and chemical standardization of botanicals and herbal preparations. J Chromatogr B 2004; 812: 23-33.
34. Parle M, Singh N. Animal models for testing memory. Asia Pac J Pharmacol 2004; 16: 101-120.
35. Morris RGM. Development of water maze procedure for studying spatial learning in rats. J Neurosci Methodol 1984; 11: 47-60.
36. D'Hooge R, De Deyn PP. Applications of the Morris water maze in the study of learning and memory. Brain Res Rev 2001; 36:60-90.
37. Itoh J, Nabeshima T, Kameyama T. Utility of an elevated plusmaze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock. Psychopharmacol 1984; 101 (1):27-33.
38. Parle M, Dhingra D. Ascorbic acid: a promising memoryenhancer in mice. J Pharmacol Sci 2003; 93:129-135.
39. Kishore K, Singh M. Effect of bacosides (alcoholic extract of Bacopa monniera Linn: Brahmi) on experimental amnesia in mice. Indian J Exp Biol 2005; 43: 640-645.
40. Ashwlayan V. D., Kishore K, Singh R. Effect of Piracetam on Anterograde and Retrograde amnesia in Der Pharmacia Lettre 2009; 1 (2):245-254.
41. Ketchmum JS, Sidell FR, Crowell EB, Aghajanian GK, Haines AH. Atropine scopolamine and ditran: comparative pharmacology and antagonist in man. Psychopharmacologia 1973; 28:121-145.
42. Brown H. Atropine, scopolamine and related anti-muscarinic drugs. J Exp Brain Res 1990; 104: 337-348.
43. Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982. 217:408-417.
44. Newhouse A. Cholinergic drug studies in dementia and depression. Adv. Exp. Biol. 1990; 282: 65-76.
45. Bandyopadhyay SK et al. The role of antioxidant activity of Phyllanthus emblica fruits on prevention from indomethacin induced gastric ulcer. J Ethnopharmacol 2000; 70: 171-176.
46. Anila L, Vijayalakshmi NR. Antioxidant action of flavonoids from Mangifera indica and Emblica officinalis in hypercholesterolemic rats. Food Chem 2003, 83: 569-574.
47. Sharma SK et al. Antiinflammatory activity of ethanol and aqueous extracts of Emblica officinalis Gaertn fruits. Hamdard Med 2003; 46:71-3.
48. Esimone CO, Nworu CS, Phytoadaptogens: an overview. Scientific research and assay 2007; 2 (2): 29-36.
49. Rosen AS, Morris ME. Anoxic depression of excitatory and inhibitory postsynaptic potentials in rat neocortical slices. J Neurophysiol 1993, 607: 54-60.
50. Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology, Art of Medicine Press, City of Industry, CA, 2004.
51. Nickerson M. Drugs. In: Goodman LS, Gilman (editors). The Pharmacological Basis of Therapeutics. New-York: Macmillan; 1975, p 727-743.
52. Greenberg LA, Lester D, Haggard HW. Reaction of hemoglobin with nitrite. J Biol Chem 1943; 151: 665-673.
53. Martinez JL, Jensen RA, Vasquez BJ, Lacob JS, Guath JL. Acquisition deficits induced by sodium nitrite. Psychopharmacol 1979; 60: 221-228.
54. Sun MK, XU H, Alkon DL. Pharmacological protection of synaptic function, spatial, learning, and memory from transient hypoxia in rats. J Pharmacol Exp Ther 2001;300: 408-416.
55. Rosen AS, Morris ME. Anoxic depression of excitatory and inhibitory postsynaptic potentials in rat neocortical slices. J Neurophysiol 1993; 607:54-60.
56. Kasa P, Rakonnczay Z, Gulayan K. The cholinergic system in Alzheimer's disease. Neurobiol 1997; 52:511-535.
57. Murphy KM, Snyder SH. Heterogeneity of adenosine A1 receptor binding in the brain tissue. Mol Pharmacol 1982, 22:250-257.
58. Van WDG, Park TS, Rubio R, Berne RM. Increases in cerebral interstitial fluid adenosine concentration during hypoxia, local potassium infusion and ischemia. J Cereb Blood flow Metab 1986; 6: 522-528.
59. Sun MK, Reis DJ (1994). Hypoxia-activated Ca+2 currents in pacemaker neurones of rat rostral ventroletral medulla invitro. J Physiol 476: 101-116.
60. Belousov AB, Gidfraind JM, Krnjevic K. Internal Ca+2 stores involved in anoxic responses of rat hippocampal neurones. J Physiol 1995; 486: 547-556.
61. Vasudevan M, Parle M. Memory enhancing activity of Anwala churna (Emblica officinalis Gaertn.): An Ayurvedic preparation. Physiol Behav 2007; 91: 46-54.
62. Chaudhuri RK. Emblica cascading antioxidant: A novel natural skin care ingredient. Skin Pharmacol Appl Skin Physiol 2002; 15: 374-380.
63. Noferi M et al. Antioxidant characteristics of hydrolysable and polyflavonoid tannins: an ESR kinetics study. J Appl Polym Sci 1997; 63: 475-482.
64. Rice-Evans, CA et al. Structure-antioxidant activity relationships of flavanoids and phenolic acids. Free Rad Biol Med 1996; 20: 933-956.
65. Jay ME. Choinesterase inhibitors in the treatment of dementia. J Am Osteopath Assoc 2005; 3:145-158.
66. Sharma HM et al. Inhibition of human low density lipoprotein oxidation invitro by Maharishi Ayurveda herbal mixture. Pharmacol Biochem Behav 1992; 43: 1175-1182.